Background Image
Table of Contents Table of Contents
Previous Page  605 / 1498 Next Page
Information
Show Menu
Previous Page 605 / 1498 Next Page
Page Background

Novel agents in Follicular NHL

PI3Kinase inhibition remains leading pathway target

Idelalisib most mature data, but

Copanlisib

Duvelisib

TG Therapeutics

Curis Incorporated – novel tagged PI3K / HDACi